This book provides a comprehensive overview of the diagnosis and management of Non-alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatis (NASH). Basic principles of disease progression, the genetic and nutritional basis of NAFLD and NASH are explained along with the proteomic principles underlying biomarker development. Chapters cover both biochemical and imaging biomarkers used in elastrography and ultrasound and discuss how these are applicable to early diagnosis and monitoring of NASH and NAFLD.  

This is a useful resource for hepatologists, primary care providers with an interest in metabolic disease, diabetologists and endocrinologists in their daily clinical practice.

Foreword

Biochemical biomarkers of NAFLD/NASH
MR based-Imaging Biomarkers in NAFLD/NASH
Detection of NAFLD/NASH in general population
Micro-vesicles in the diagnosis and monitoring of NASH
Non-invasive biomarkers for monitoring NASH: NASH resolution and Fibrosis regression
From transcriptome to proteomic in the development of biomarkers in NAFLD/NASH
Transient elastography and ultrasound as imaging biomarkers in NAFLD/NASH
Early detection of HCC in patients with NAFLD/NASH
Genes and NAFLD/NASH progression
Geometry of nutrition: micronutrients and NAFLD progression
Psychological biomarkers profile in NAFLD/NASH with advanced fibrosis
Integrative proposal of biomarkers use in clinical practice management of NAFLD/NASH.